Protyon
Entity

  • Protyon

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    473

  • Activities

    deeptech healthtech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Groningen, Netherlands

    Groningen

    Netherlands

  • Employees

    Scale: 2-10

    Estimated: 7

  • Engaged corporates

    1
    0 1

  • Added in Motherbase

    1 year, 4 months ago
Description
  • Value proposition

    Guiding clinicians towards personalized treatment and enhancing quality of life for patients

    Using molecular structures to choose the best therapy. Currently focusing on mutations in EGFR and other lung cancer drivers. Working closely with the Molecular Tumor Board at the UMCG #umcg and patient organizations across Europe.

  • Home - Protyon

    Supporting the clinical decision-making process to choose the best available therapy for patients.

    • https://protyon.tech/
Corporate interactions BETA
Corporate TypeTweets Articles
ITC Europe
ITC Europe
Insurance, Events Services
ITC Europe
Insurance, Events Services 		Other

31 May 2024


Similar entities
Last news
Show all articles
Social network dynamics